lifestyle

Semaglutide vs Metformin for Weight Loss Reviewed in Detail

James Madison, GLP-1 Expert

James Madison, GLP-1 Expert

Jul 12, 2025

Jul 12, 2025

Semaglutide vs Metformin for Weight Loss Reviewed in Detail

Weight management can be a complex journey, especially with so many treatment options promising quick results but often leading to frustration. Two widely discussed medications for weight loss, semaglutide and metformin, offer different mechanisms and outcomes worth exploring. Additionally, Does Semaglutide Cause Constipation?

This guide breaks down the key differences between semaglutide and metformin in terms of safety, efficacy, and long-term benefits—all within the broader context of GLP-1 Medication Management. To further support your goals, our GLP-1 app helps manage your medication plan, track your progress, and stay on course—whether you choose semaglutide, metformin, or both as part of your weight loss strategy.

Table of Contents

What Is Semaglutide?

What Is Semaglutide

How Semaglutide Works in the Body

Semaglutide works in a unique way by acting like GLP-1, a hormone that occurs naturally in the body. It helps control blood sugar levels and affects appetite. Semaglutide functions as a messenger that sends signals to different parts of the body to help manage blood sugar and appetite.

For a deeper dive into GLP‑1 injection management, see how to optimize your routine.

Effects on the Brain and Digestion

Semaglutide targets certain areas in the brain. This action creates a feeling of fullness, which makes people eat less.

It also slows how fast food leaves the stomach. This means food stays in the stomach longer, helping people feel satisfied for more time.

The combined effects of semaglutide make it helpful for people struggling to manage their weight, especially those with a high body mass index (BMI).

What Is Semaglutide Prescribed For?

Semaglutide is primarily prescribed for the treatment of type 2 diabetes mellitus and to prevent major cardiovascular events in diabetes patients. However, it is also used for chronic weight management in obese or overweight patients.

The FDA has approved semaglutide for chronic weight management under the brand name Wegovy.

Ozempic and Rybelsus are commonly prescribed off-label for weight management.

Who Makes Semaglutide?

Novo Nordisk, a Danish-based pharmaceutical company specializing in diabetes medication, manufactures all three semaglutide medications. The three FDA-approved brands include Ozempic, Rybelsus, and Wegovy.  Ozempic and Wegovy are both once-weekly subcutaneous injections, so their dosing schedule is similar. Rybelsus is the only oral GLP-1 receptor agonist currently available.

Related Reading

What Is Metformin?

What Is Metformin

Metformin is a medication that helps lower blood glucose levels. Like semaglutide, it is primarily prescribed for the treatment of type 2 diabetes mellitus. 

While semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, metformin belongs to a drug class called biguanides.  Biguanides are oral diabetes medications that lower blood glucose levels. 

The active compound in metformin is metformin hydrochloride, which is available by prescription in various forms under the brand names Axpinet, Diagemet, Glumetza, Glucient, Glucophage, Fortamet, Riomet, and Metabet.  

The drug is available as tablets, a liquid to swallow, and dissolvable powder. Metformin is primarily used for lowering blood glucose levels in patients with type 2 diabetes mellitus, gestational diabetes, patients with prediabetes, and sometimes in women with polycystic ovary syndrome (PCOS) who have insulin resistance.  

Like semaglutide, metformin is also prescribed off-label to assist with weight loss and help those with weight-related issues, such as high cholesterol and high blood pressure. 

Discover the Types of GLP‑1 Drugs & Brands to compare how they align with metformin.

How Metformin Works

Metformin mainly acts on the liver to lower the production of glucose, which helps bring down blood sugar levels.  It also improves insulin sensitivity, allowing the body to use insulin more effectively. This can be thought of as making delivery trucks that carry glucose to cells work more efficiently.  Unlike medications that stimulate insulin production, metformin does not increase insulin output. Instead, it enhances the body's ability to utilize the insulin it already produces, making it an effective tool in diabetes management.

Related Reading

  • How Long Does It Take for GLP-1 to Work

  • Can Semaglutide Affect Your Period

  • Does GLP-1 Make You Tired

  • Best Time of Day to Take Semaglutide for Weight Loss

  • How Long Does It Take for Semaglutide to Suppress Appetite

  • GLP-1 Constipation

  • How Long Do Semaglutide Side Effects Last

  • GLP-1 Dosage for Weight Loss

Semaglutide vs Metformin for Weight Loss

Semaglutide vs Metformin for Weight Loss

Metformin can be taken by adults and children 10 and older.

Ozempic is only available for adults.

It is necessary to speak with a healthcare provider if pregnancy is planned or occurs while using these drugs. Both metformin and Ozempic can be harmful to the fetus. Ozempic should be discontinued at least two months before becoming pregnant.

Metformin vs Semaglutide How They Work

How Semaglutide Affects GLP-1 Receptors

The mechanism of action for semaglutide is activating GLP-1 receptors in response to the body eating. First, GLP-1 receptors in the pancreas increase insulin secretion, causing blood sugar levels to decrease. GLP-1 also lowers blood sugar levels by reducing the release of glucagon, a compound that prevents glucose from entering the blood.

Semaglutide also slows gastric emptying, which helps prevent spikes in blood sugar levels and slows the rate at which nutrients are absorbed. This helps improve satiety and reduce hunger by keeping the individual full for hours. In higher doses, semaglutide also triggers the brain to reduce appetite.

How Metformin Targets the Liver and Muscles

Metformin is quite different in that it primarily targets the muscles and liver. It does not directly stimulate insulin secretion but helps the body use insulin more efficiently.

Metformin affects blood sugar levels by decreasing glucose production in the liver (gluconeogenesis) and improving insulin sensitivity in muscle cells. Improving insulin sensitivity in the muscle cells allows them to use more glucose from the bloodstream and can help prevent fat storage. Metformin also decreases the amount of blood sugar that the liver produces and that the stomach or intestines absorb.

In other words, it reduces the absorption of fats in the intestines, which can prevent weight gain or promote fat loss. Like semaglutide, metformin also reduces appetite to promote weight loss.

The Role of AMPK in Metformin's Mechanism

Another important action of metformin is that it activates the enzyme AMP-activated protein kinase (AMPK).

AMPK stimulates insulin production and glucose transport in muscles and regulates cellular and organ metabolism. Since metformin increases the effects of insulin without actually increasing insulin secretion, it is referred to as an insulin sensitizer.

The primary difference in the mechanism of action is that semaglutide directly stimulates insulin secretion, whereas metformin does it indirectly.

Metformin vs Semaglutide Weight Loss

Semaglutide Shows Significant Early Results

Semaglutide has been proven highly effective for reducing body weight and supporting sustained weight loss. One study had 175 overweight or obese patients take weekly semaglutide injections of 1.7 or 2.4 mg for six months.

After three months, patients had an average drop in body weight of 5.9% and lost an average of 14.7 lbs (6.7 kg). After six months, users lost 10.9% of total body weight and an average of 27.1 lbs (12.3 kg).

Metformin Yields Modest Weight Loss

To compare, one study evaluated weight loss after six months of metformin at doses up to 2,500 mg daily. The average weight loss in the metformin group was approximately 12.8 lbs (5.8 kg).

So, after six months, users on semaglutide lost an average of 27.1 lbs (12.3 kg) compared to only 12.8 lbs (5.8 kg) with metformin.

Semaglutide Outpaces Metformin in Time and Effectiveness

Semaglutide users experienced significant weight loss in only three months (14.7 lbs), while metformin users required six months to achieve a smaller reduction.

Dosing & Administration

One of the main differences between metformin and semaglutide is how they are administered. Metformin is strictly an oral medication, available in tablet form to be taken once or twice daily. It is offered in both extended-release (ER) and immediate-release (IR) formulations.

Metformin Dosing Guidelines

The typical starting dose for metformin is 500 mg once daily, taken with the last meal of the day. Dosing is generally adjusted to 500 mg twice daily or 850 mg once daily, depending on blood sugar levels.

Physicians typically avoid prescribing more than 2,000 mg per day to minimize unwanted side effects.

Comparison with Semaglutide

Given the variety of available metformin brands, the typical dosing is often compared to that of semaglutide. Semaglutide has been proven safe for up to 68 weeks or longer, making it suitable for long-term use when side effects are manageable and it is approved by a healthcare provider.

Metformin has also been validated for long-term use. However, both medications should be discontinued once the individual achieves their weight loss goal.

Semaglutide and Metformin Each Have Their Own Unique Risks

Ozempic and metformin both have reputations for causing digestion-related side effects, including nausea, vomiting, and diarrhea. But they also carry distinct risks that are important to consider.

Risks Associated With Semaglutide

While rare, pancreatitis (inflammation of the pancreas) and gallbladder disease have been linked to GLP-1 agonists, including Ozempic. Animal studies have also shown an increased risk of thyroid C-cell tumors with these medications, but this risk hasn’t been confirmed in people.

It’s also possible that diabetes-related eye problems may worsen while taking Ozempic.

Risks Associated With Metformin

Lactic acidosis (too much lactic acid in the blood) is a rare but serious metformin side effect. If kidney function is impaired, the risk of lactic acidosis becomes even higher.

Because of this, healthcare providers typically monitor kidney function during metformin treatment to ensure it remains a safe option. Depending on the results, a lower dose may be prescribed or metformin may be discontinued.

Balancing Benefits and Risks

For most people taking Ozempic and metformin, the benefits of the medications outweigh their potential risks.

Metformin versus Ozempic

Ozempic, a form of semaglutide, is a once-weekly subcutaneous injection typically administered in the upper arm, thigh, or stomach on a rotating schedule. Ozempic users begin with 0.25 mg for the first month to slowly introduce the compound and monitor side effects before increasing to 0.50 mg during the maintenance phase.

Users may increase the dose to 1 mg or a maximum of 2 mg per week if necessary. The injection can be taken at any time of day, provided it is on the same day each week. The Ozempic starter dose of 0.25 mg is comparable to the initial 500 mg once-daily dose of metformin. Dosage adjustments are possible as long as side effects remain manageable.

Rybelsus vs Metformin

Rybelsus is the most similar type of semaglutide to metformin because it is a daily oral tablet. Rybelsus users start at 3 mg for the first month, then increase to 7 mg as needed, with a max dose of 14 mg.

Rybelsus has strict dosing protocols, requiring the dose to be taken first thing in the morning at the same time every day, 30–60 minutes before eating, with water. Metformin is usually taken twice daily, with breakfast and the final meal. The dosing protocol is not as strict with metformin, but users taking it once daily should take it at night with their final meal.

Metformin vs Wegovy

Wegovy is similar to Ozempic in dosing protocol because they are nearly identical. Wegovy is also a once-weekly injection, where users start at 0.25 mg for the first month before increasing to 0.5 mg. Wegovy also has 1.0 mg, 1.7 mg, and a maximum of 2.4 mg.

Wegovy has slightly higher doses than Ozempic because it is explicitly designed to promote weight loss. In higher doses like Wegovy, semaglutide can act as a powerful appetite suppressant.

Semaglutide vs Metformin Side Effects

Both medications affect the digestive system and tend to cause similar side effects, primarily involving gastrointestinal issues. If any adverse effects occur, contact a healthcare provider immediately.

Who Should Avoid These Medications

Metformin is approved for use in children aged ten and older with diabetes, while semaglutide is only approved for adults.

Certain populations should avoid taking metformin or semaglutide due to potential health risks. The following points summarize the key considerations:

  • Thyroid issues or thyroid tumors

  • Gastrointestinal disorders

  • History of pancreatitis

  • Kidney or liver issues

  • Cardiovascular disease or issues

  • Women who are pregnant, breastfeeding, or planning on becoming pregnant

  • Medical history of diabetic ketoacidosis

  • Family history of medullary thyroid carcinoma

Alcohol Considerations

Alcohol consumption should be avoided while taking these medications. Drinking alcohol can interfere with blood sugar regulation, increasing the risk of hypoglycemia.

Brand Names

Semaglutide is available under the brand names Ozempic (for diabetes management) and under the brand name Wegovy (for weight loss).

Common brand-name products for metformin are Fortamet and Glumetza (XR version).

Who Can Use

Metformin can be taken by adults and children 10 and older.

Ozempic is only available for adults. Learn about Who Can Prescribe GLP-1 and how to access these medications safely.

It is necessary to speak with your healthcare provider if you become pregnant or plan to become pregnant while on these drugs. Both metformin and Ozempic can be harmful to the fetus. Ozempic should be stopped at least two months before becoming pregnant.

Related Reading

  • Does Semaglutide Make You Tired

  • Tirzepatide vs Semaglutide Side Effects

  • Microdosing Semaglutide

  • How to Speed Up Weight Loss on Semaglutide

  • Best GLP-1 Supplements

  • How Fast Does Semaglutide Work for Weight Loss

  • Which GLP-1 is Best for Weight Loss

  • Can You Take Semaglutide With High Blood Pressure Medication

  • How Long Do You Stay on Semaglutide for Weight Loss

Download our GLP-1 app to Turn Your Weight Loss Journey into Your Favorite Game

Starting Ozempic, Wegovy, or Mounjaro? These medications can support weight loss, but avoiding unpleasant side effects such as muscle loss and severe constipation requires intentional effort.

MeAgain transforms that effort into an engaging experience through an adorable capybara character that helps users meet their goals for protein intake, fiber, hydration, and physical activity.

Users can also document their progress with the Journey Card, a visual tracker that captures every milestone—ideal when transformation happens quickly.

It’s the only all-in-one GLP-1 app that makes staying healthy feel as rewarding as the results themselves.